In this episode, we get an insight into the current COVID-19 landscape from a rheumatologist’s perspective.
Rheum Advisor on Air
Jane Salmon, MD, takes us on a deep dive into identifying and predicting the risk for pregnancy complications in patients with lupus and APS.
In this episode, we discuss the importance of addressing mental health in the pediatric rheumatology population.
In this episode, Anisha Dua, MD, gives us a brief insight into the various challenges observed with large vessel vasculitis imaging.
In this episode, Stanley Cohen, MD, provides a glimpse into the scope and new updates to the ACR RA treatment guidelines.
In this episode, we discuss the role of pegloticase treatment in gout, as presented at ACR Convergence 2020.
In this episode, we discuss how the the microbiome can play a role in the potential treatment of rheumatic diseases.
In this episode, we’re highlighting the importance of recognizing and discussing women’s health – from premenstruation through menstruation and pregnancy and menopausal transition – in rheumatology.
In this episode, we’re taking a deep dive into the role of digital health technologies in rheumatology care and disease management.
In this episode, we get further insight into the current state of biosimilars development and adoption in the United States vs other countries, interchangeability among adult and pediatric patients with rheumatologic conditions, nonmedical switching to biosimilars, and an overview of its potential cost benefits for the US healthcare system.
In this episode, we get expert perspectives on the immunopathology and management of the cytokine storm in adult and pediatric patients with COVID-19.
In this episode, we highlight and address the disproportionate burden of rheumatic diseases and COVID-19 in ethnic minorities and the gender disparities observed in rheumatology care.
In part 2 of this series, we’re getting perspectives from an allopathic and an osteopathic physician specializing in rheumatology on the evolution of telemedicine and what the future may look like for the management of rheumatologic conditions.
Telemedicine in rheumatology, or telerheumatology, may be the future of diagnosis and treatment in rheumatology. In this 2-part episode series, we’re delving deeper into the world of telerheumatology and asking, “Will this be the new normal?”
In this episode, we discuss the effect of the COVID-19 pandemic on the health of rheumatologists and how this may have an impact on delivering patient care.